Evidence map›Paper›PMID 29784807›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Oocyte stage-specific effects of MTOR determine granulosa cell fate and oocyte quality in mice.

Jing Guo, Teng Zhang, Yueshuai Guo, Tao Sun, Hui Li, Xiaoyun Zhang, Hong Yin, Guangyi Cao, Yaoxue Yin, Hao Wang and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 161 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The role of mTOR signaling in regulating the quality of mammalian oocytes.Journal of assisted reproduction and genetics · 2026
    Review
  7. Translational Fidelity Decline in the Aging Oocyte and Embryo Development.International journal of molecular sciences · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Susceptibility of Brca1Cancer science · 2025
    Article
  18. Review
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Jing GuoState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
Teng ZhangState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
Yueshuai GuoState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
Tao SunState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
Hui LiState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
Xiaoyun ZhangState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
Hong YinState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
Guangyi CaoState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
Yaoxue YinState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
Hao WangState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
Lanying ShiState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
Xuejiang GuoState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.ORCID 0000-0002-0475-5705
Jiahao ShaState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China.
John J EppigThe Jackson Laboratory, Bar Harbor, ME 04609; youqiang.su@njmu.edu.cn john.eppig@jax.org.
You-Qiang SuState Key Laboratory of Reproductive Medicine, Nanjing Medical University, 211166 Nanjing, People's Republic of China; youqiang.su@njmu.edu.cn john.eppig@jax.org.ORCID 0000-0003-3537-6246
Nanjing Medical University · CNFudan University · CNJackson Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MTOR (mechanistic target of rapamycin) is a widely recognized integrator of signals and pathways key for cellular metabolism, proliferation, and differentiation. Here we show that conditional knockout (cKO) of

Indexed as

AnimalsCell DifferentiationCells, CulturedFemaleFollicle Stimulating HormoneGranulosa CellsInfertility, FemaleMeiosisMiceMice, Inbred C57BLMice, KnockoutOocytesOogenesisOvarian FollicleTOR Serine-Threonine KinasesFollicle Stimulating HormonemTOR protein, mouseTOR Serine-Threonine Kinasesfemale infertilitygranulosa cellmeiosisoocyte-expressed MTORSertoli-like cells

Identifiers

PMID29784807
PMCPMC6003357
OpenAlexW2804054946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.